You are here

  • Home
  • Archive
  • Volume 5, Issue 3
  • Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial

Citation Tools

Article menu
XML
Infectious diseases
Protocol
Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rosso-Fernández C, Sojo-Dorado J, Barriga A, et al
Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
BMJ Open 2015;5:e007363. doi: 10.1136/bmjopen-2014-007363